Author

Li Ou

ORCID 0000-0002-7743-5649Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Li Ou1 paper · Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA;

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:multiome· 1

Frequent Co-Authors

Adrienne SalletsiD· 1 shared Anushtha SharmaiD· 1 shared Chris S. RaeiD· 1 shared Colin J. McKinlayiD· 1 shared Daniel J. FernandeziD· 1 shared Daniel O. FrimannssoniD· 1 shared Diane M Da Silva· 1 shared Edward E. LemmensiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adrienne SalletsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintSep 24, 2025

NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability.

Meredith L.L. Leong, Weiqun Liu, Nicole C. Fay…·Ole Audun Werner Haabeth

This paper introduces NTX250, an mRNA-based immunotherapy platform for HPV-associated cancers that induces tumor regression and durable immune memory in preclinical models.

DOI 10.1101/2025.09.24.678202

multiomeexperimental assay

𝕏 PostBluesky